Home Sequana Medical

Sequana Medical

In operation
Post-IPO Round
Developer of Antidiuretic Fluid Overload Treatment Solutions

Basic Information

Sequana Medical NV is a pioneer in the treatment of fluid overload, a serious clinical complication commonly seen in patients with liver disease, heart failure, and cancer. These patients may have up to 15 liters of excess fluid in their bodies, leading to significant medical issues including increased mortality, repeated hospitalizations, severe pain, breathing difficulties, and restricted mobility, all of which severely impact daily life. Although diuretics are the standard treatment, the problem is that for many patients, they are no longer effective. Sequana Medical is seeking to provide innovative treatment solutions for this large and growing population of "diuretic-resistant" patients. alfapump® and DSR® are Sequana Medical's proprietary platforms that work with the body to treat antidiuretic fluid overload, offering substantial clinical and quality-of-life benefits to patients while reducing healthcare system costs.
Sequana Medical NV
Belgium
51~100 people
January 01, 2006
info@sequanamedical.com